101 related articles for article (PubMed ID: 12574669)
21. Glycemia and cognitive function in older adults using glucose-lowering drugs.
Shorr RI; de Rekeneire N; Resnick HE; Yaffe K; Somes GW; Kanaya AM; Simonsick EM; Newman AB; Harris TB
J Nutr Health Aging; 2006; 10(4):297-301. PubMed ID: 16886100
[TBL] [Abstract][Full Text] [Related]
22. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia.
Draelos MT; Jacobson AM; Weinger K; Widom B; Ryan CM; Finkelstein DM; Simonson DC
Am J Med; 1995 Feb; 98(2):135-44. PubMed ID: 7847430
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.
Lobnig BM; Krömeke O; Optenhostert-Porst C; Wolf OT
Diabet Med; 2006 Jan; 23(1):32-9. PubMed ID: 16409563
[TBL] [Abstract][Full Text] [Related]
24. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
[TBL] [Abstract][Full Text] [Related]
25. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
Spellman CW
J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
[TBL] [Abstract][Full Text] [Related]
26. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
Edelman SV; Callahan P; Deeb LC
Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
[TBL] [Abstract][Full Text] [Related]
27. Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
Abbatecola AM; Bo M; Armellini F; D'Amico F; Desideri G; Falaschi P; Greco A; Guerrini G; Lattanzio F; Volpe C; Paolisso G
Metabolism; 2015 Nov; 64(11):1500-6. PubMed ID: 26318195
[TBL] [Abstract][Full Text] [Related]
28. Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study.
Gómez-Martínez C; Babio N; Júlvez J; Becerra-Tomás N; Martínez-González MÁ; Corella D; Castañer O; Romaguera D; Vioque J; Alonso-Gómez ÁM; Wärnberg J; Martínez JA; Serra-Majem L; Estruch R; Tinahones FJ; Lapetra J; Pintó X; Tur JA; López-Miranda J; Bueno-Cavanillas A; Gaforio JJ; Matía-Martín P; Daimiel L; Martín-Sánchez V; Vidal J; Vázquez C; Ros E; Dalsgaard S; Sayón-Orea C; Sorlí JV; de la Torre R; Abete I; Tojal-Sierra L; Barón-López FJ; Fernández-Brufal N; Konieczna J; García-Ríos A; Sacanella E; Bernal-López MR; Santos-Lozano JM; Razquin C; Alvarez-Sala A; Goday A; Zulet MA; Vaquero-Luna J; Diez-Espino J; Cuenca-Royo A; Fernández-Aranda F; Bulló M; Salas-Salvadó J
Front Endocrinol (Lausanne); 2021; 12():754347. PubMed ID: 34777250
[TBL] [Abstract][Full Text] [Related]
29. Cognitive performance associated with self-care activities in Mexican adults with type 2 diabetes.
Compeán-Ortiz LG; Gallegos EC; Gonzalez-Gonzalez JG; Gomez-Meza MV; Therrien B; Salazar BC
Diabetes Educ; 2010; 36(2):268-75. PubMed ID: 20179249
[TBL] [Abstract][Full Text] [Related]
30. Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection.
Yang J; Jacobson LP; Becker JT; Levine A; Martin EM; Munro CA; Palella FJ; Lake JE; Sacktor NC; Brown TT
AIDS; 2018 Aug; 32(13):1849-1860. PubMed ID: 29746300
[TBL] [Abstract][Full Text] [Related]
31. Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes.
Jensen NJ; Nilsson M; Ingerslev JS; Olsen DA; Fenger M; Svart M; Møller N; Zander M; Miskowiak KW; Rungby J
Eur J Endocrinol; 2020 Feb; 182(2):233-242. PubMed ID: 31821157
[TBL] [Abstract][Full Text] [Related]
32. A pilot study to examine the correlation between cognition and blood biomarkers in a Singapore Chinese male cohort with type 2 diabetes mellitus.
Goh DA; Dong Y; Lee WY; Koay WI; Tay SZ; Soon D; Chen C; Brittain CF; Lowe SL; Wong BS
PLoS One; 2014; 9(5):e96874. PubMed ID: 24816647
[TBL] [Abstract][Full Text] [Related]
33. Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control.
Naor M; Steingrüber HJ; Westhoff K; Schottenfeld-Naor Y; Gries AF
J Diabetes Complications; 1997; 11(1):40-6. PubMed ID: 9025012
[TBL] [Abstract][Full Text] [Related]
34. Cognitive Dysfunction: Part and Parcel of the Diabetic Foot.
Natovich R; Kushnir T; Harman-Boehm I; Margalit D; Siev-Ner I; Tsalichin D; Volkov I; Giveon S; Rubin-Asher D; Cukierman-Yaffe T
Diabetes Care; 2016 Jul; 39(7):1202-7. PubMed ID: 27208339
[TBL] [Abstract][Full Text] [Related]
35. Cognitive function in younger type II diabetes.
Dey J; Misra A; Desai NG; Mahapatra AK; Padma MV
Diabetes Care; 1997 Jan; 20(1):32-5. PubMed ID: 9028690
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychological function in older subjects with non-insulin-dependent diabetes mellitus.
Atiea JA; Moses JL; Sinclair AJ
Diabet Med; 1995 Aug; 12(8):679-85. PubMed ID: 7587006
[TBL] [Abstract][Full Text] [Related]
37. Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging Study.
Mimenza-Alvarado AJ; Jiménez-Castillo GA; Yeverino-Castro SG; Barragán-Berlanga AJ; Pérez-Zepeda MU; Ávila-Funes JA; Aguilar-Navarro SG
BMC Geriatr; 2020 Oct; 20(1):424. PubMed ID: 33096995
[TBL] [Abstract][Full Text] [Related]
38. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.
Vanhanen M; Koivisto K; Karjalainen L; Helkala EL; Laakso M; Soininen H; Riekkinen P
Neuroreport; 1997 Apr; 8(6):1527-30. PubMed ID: 9172168
[TBL] [Abstract][Full Text] [Related]
39. Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly.
Raizes M; Elkana O; Franko M; Ravona Springer R; Segev S; Beeri MS
J Alzheimers Dis; 2016; 49(3):589-92. PubMed ID: 26484908
[TBL] [Abstract][Full Text] [Related]
40. Combined exercise training improves specific domains of cognitive functions and metabolic markers in middle-aged and older adults with type 2 diabetes mellitus.
Silveira-Rodrigues JG; Pires W; Gomes PF; Ogando PHM; Melo BP; Aleixo IMS; Soares DD
Diabetes Res Clin Pract; 2021 Mar; 173():108700. PubMed ID: 33600868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
